CRA has provided economic assessments of competition in connection with several mergers of clinical laboratories. CRA has analyzed the degree of competition from hospital and physician-owned labs, the nature of bidding for capitated lab arrangements with providers, and the extent to which a national market exists for contracts with health plans exists.
CRA Competition's response to EU Draft Merger Guidelines: An economic perspective on the emerging framework
Our European Competition team has contributed to the economic assessment in nearly a third of distinct merger decisions cited in the draft, (46 out of 164)...